Patient Advocacy and Support

A Legacy of Resilience: Sharsheret’s Year-End Appeal Honors Founder Rochelle Shoretz’s Vision

• Patient Advocacy and Support

A Legacy of Resilience: Sharsheret’s Year-End Appeal Honors Founder Rochelle Shoretz’s Vision

Nana Muazin July 18, 2026

By [Your Name/Journalist Name] December 1, 2025 TEANECK, N.J. — In the landscape of non-profit healthcare advocacy,...

Read More Read more about A Legacy of Resilience: Sharsheret’s Year-End Appeal Honors Founder Rochelle Shoretz’s Vision

Navigating the Uncharted Waters: Essential Resources for Families Facing Parental Cancer Diagnoses

• Patient Advocacy and Support

Navigating the Uncharted Waters: Essential Resources for Families Facing Parental Cancer Diagnoses

Sagoh July 17, 2026

A significant percentage of cancer patients are parents, underscoring the critical need for comprehensive support systems to...

Read More Read more about Navigating the Uncharted Waters: Essential Resources for Families Facing Parental Cancer Diagnoses

The Precision Revolution: Navigating the Risk of Breast Cancer Recurrence Through Genomic Insights

• Patient Advocacy and Support

The Precision Revolution: Navigating the Risk of Breast Cancer Recurrence Through Genomic Insights

Nila Kartika Wati July 17, 2026

The moment a patient hears the words, “You have breast cancer,” the world undergoes an instantaneous and...

Read More Read more about The Precision Revolution: Navigating the Risk of Breast Cancer Recurrence Through Genomic Insights

The Pink Legacy: Elizabeth Hurley and the Three-Decade Crusade Against Breast Cancer

• Patient Advocacy and Support

The Pink Legacy: Elizabeth Hurley and the Three-Decade Crusade Against Breast Cancer

Ali Ikhwan July 17, 2026

Introduction: A Night of Philanthropy and Remembrance In the high-stakes world of global philanthropy, few events carry...

Read More Read more about The Pink Legacy: Elizabeth Hurley and the Three-Decade Crusade Against Breast Cancer

Resilience in Motion: Miriam Savetsky’s Journey from Diagnosis to the Marathon Finish Line

• Patient Advocacy and Support

Resilience in Motion: Miriam Savetsky’s Journey from Diagnosis to the Marathon Finish Line

Rifan Muazin July 17, 2026

The phrase "1 in 8" is a common clinical statistic in the world of oncology, but for...

Read More Read more about Resilience in Motion: Miriam Savetsky’s Journey from Diagnosis to the Marathon Finish Line

Unlocking Breast Cancer Risk: The Tyrer-Cuzick Model and Empowering Early Detection

• Patient Advocacy and Support

Unlocking Breast Cancer Risk: The Tyrer-Cuzick Model and Empowering Early Detection

Basiran July 17, 2026

Introduction Breast cancer remains a formidable health challenge, affecting an estimated one in eight women in the...

Read More Read more about Unlocking Breast Cancer Risk: The Tyrer-Cuzick Model and Empowering Early Detection

The New Frontier of Metastatic Breast Cancer: Precision Sequencing and Proactive Intervention at ASCO 2026

• Patient Advocacy and Support

The New Frontier of Metastatic Breast Cancer: Precision Sequencing and Proactive Intervention at ASCO 2026

Basiran July 17, 2026

CHICAGO — The 2026 American Society of Clinical Oncology (ASCO) Annual Meeting has marked what many experts...

Read More Read more about The New Frontier of Metastatic Breast Cancer: Precision Sequencing and Proactive Intervention at ASCO 2026

The Architecture of Empathy: How Peer Support Reshapes the Trajectory of Familial Cancer Care

• Patient Advocacy and Support

The Architecture of Empathy: How Peer Support Reshapes the Trajectory of Familial Cancer Care

Nila Kartika Wati July 16, 2026

By [Staff Writer/Journalist] Published: January 30, 2026 The diagnosis of a parent with a life-threatening illness is...

Read More Read more about The Architecture of Empathy: How Peer Support Reshapes the Trajectory of Familial Cancer Care

FDA Approves Gedatolisib (Revtorpyk) for Advanced HR+/HER2- Breast Cancer: A New Paradigm in Overcoming Endocrine Resistance

• Patient Advocacy and Support

FDA Approves Gedatolisib (Revtorpyk) for Advanced HR+/HER2- Breast Cancer: A New Paradigm in Overcoming Endocrine Resistance

Evan Lee Salim July 16, 2026

The landscape of metastatic breast cancer treatment has reached a significant milestone with the U.S. Food and...

Read More Read more about FDA Approves Gedatolisib (Revtorpyk) for Advanced HR+/HER2- Breast Cancer: A New Paradigm in Overcoming Endocrine Resistance

Beyond the Dollar: Cultivating Community and Awareness Through Breast Cancer Fundraising

• Patient Advocacy and Support

Beyond the Dollar: Cultivating Community and Awareness Through Breast Cancer Fundraising

Lina Hope July 16, 2026

August 20, 2025 – As Breast Cancer Awareness Month approaches, the National Breast Cancer Foundation (NBCF) is...

Read More Read more about Beyond the Dollar: Cultivating Community and Awareness Through Breast Cancer Fundraising